Early cavity detection: Interview with CaviSense CEO Jordan Rubinson
What if your dentist could spot cavities long before they became a problem? Join us as we chat with Jordan Rubinson, CEO of CaviSense, about his interesting journey from pharma to medtech.
We start by discussing Jordan's early influences, from his father's career at Block Drug Company to his own academic adventures at Columbia and MIT's Sloan School. Despite an initial interest in accounting, Jordan's passion for pharma led him down a path less traveled, avoiding the conventional business routes of consulting and investment banking.
Next, we take a closer look at Jordan's dynamic career in the pharmaceutical industry. Learn how his family's frequent relocations led to professional opportunities across the globe. Jordan shares anecdotes from his time in big pharma, including his experiences within a management development program at Sanofi Pasteur and the challenges of managing diverse roles in different markets.
His shift from big pharma to the innovative medtech startup scene in Israel provides a compelling narrative about the contrasts between structured environments and the fast-paced, resource-tight nature of startups. Finally, we explore the evolving role of dentists as both medical professionals and entrepreneurs. Discover how new technologies are revolutionizing dental care, especially in pediatric dentistry.
Jordan introduces us to CaviSense, a groundbreaking tool for early cavity detection, and discusses its journey from early development to FDA registration. We also touch on the exciting future of consumer-friendly dental monitoring tools that could transform how we manage oral health at home.
Health Business Group is a boutique healthcare consulting firm that develops growth strategies for innovative healthcare companies such as CaviSense. Contact us to learn more.
